At MidCity TMS, we are dedicated to offering cutting-edge treatments for Depression, including Spravato (esketamine) nasal spray, a groundbreaking therapy approved by the FDA for treatment-resistant Depression (TRD) and major depressive disorder with suicidal ideation (MDSI). Our mission is to provide comprehensive, personalized care to help our patients achieve mental and emotional wellness.
What is Spravato?
Spravato (esketamine) is a revolutionary nasal spray treatment usually used for adults who have not adequately benefited from at least two other antidepressant treatments. Unlike traditional antidepressants, which can take at least 4-6 weeks to become effective, Spravato offers rapid relief from depressive symptoms, often within hours to days. This makes it an invaluable option for patients struggling with severe Depression.